红星资本局8月2日消息，第12批国家组织药品集中带量采购（简称“集采”）于7月31日开标，共有65种药品全部采购成功，覆盖抗感染、抗肿瘤、抗血栓、降血糖、降血压、降血脂、风湿免疫、消炎镇痛等领域常用药品。 红星资本局注意到，本次集采共有327家企业的521个产品获得拟中选资格，其中就包括诺华的心衰“药王”沙库巴曲缬沙坦等多款备受关注的原研药。国内药企方面，齐鲁药业、科伦药业（002422.SZ）...
Source Link红星资本局8月2日消息，第12批国家组织药品集中带量采购（简称“集采”）于7月31日开标，共有65种药品全部采购成功，覆盖抗感染、抗肿瘤、抗血栓、降血糖、降血压、降血脂、风湿免疫、消炎镇痛等领域常用药品。 红星资本局注意到，本次集采共有327家企业的521个产品获得拟中选资格，其中就包括诺华的心衰“药王”沙库巴曲缬沙坦等多款备受关注的原研药。国内药企方面，齐鲁药业、科伦药业（002422.SZ）...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.